The Might of Molecular

Affordable, Rapid, and Accurate Point-of-Care Diagnostics for Family & Women’s Health

A New Era of Diagnostics for Better Health Outcomes

Fast & Accurate Results*

Less Than One Minute Hands-On Time

Advanced Multiplex Technology**

Test-to-Treat

The DX 100™ Platform

Our innovative diagnostic platform is designed to provide both healthcare professionals and patients with fast, accurate, and reliable results. Experience a new era in diagnostics that prioritizes efficiency, affordability, and accuracy, ensuring you get the answers you need quickly.

*The clinical study for the AmplifiDx COVID-19 Assay™  (Detection of SARS-CoV-2) on the DX 1000 System™ (First-Generation Instrument) resulted in a 97.8% PPA and 100% NPA (Comparator: Roche cobas® liat).

**The DX 100™ Platform can detect up to 10 analytes.

Developing Point-of-Need Molecular Diagnostics

Sexual Health

Family & Women’s Health

Not Cleared or approved by the FDA

About Us

Vision

AmplifiDx envisions a future where advanced diagnostics are accessible worldwide, improving global health outcomes.

Mission

AmplifiDx is combatting the spread of infectious diseases by enabling global access to fast, accurate, and simple point-of-care testing.

Meet the Team

  • Nancy Schoenbrunner

    Chief Executive Officer

  • Shoulian Dong

    Chief Scientific Officer

  • Daniel Schoener

    Chief Product Officer

  • Chris Meda

    Chief Commercial Officer

How Did We Get Here?

Contact us.

info@amplifidx.com
617-510-3664

Agility Labs

39655 Eureka Drive

Newark, CA 94560

Bioburst.io

764 Main Street

Waltham, MA 02451